Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Burden and Health System Challenges in MASLD Across East and Southeast Asia: A Narrative Review.

Health science reports·2026
Same author

Fueling or Fighting Cancer? The Thermogenic Paradox of Brown Adipose Tissue.

Current obesity reports·2026
Same author

8-O-acetylharpagide, an active compound isolated from <i>A. taiwanensis</i> selectively induced G2/M phase arrest and radiosensitivity in hypopharyngeal cancer cells.

Biochemistry and biophysics reports·2026
Same author

Modular assembly of chiral amino acid derivatives and peptides from commonly available feedstocks.

Nature communications·2025
Same author

Plasma levels of adrenaline, noradrenaline, dopamine, serotonin, and cortisol in sarcopenia: comparison with non-sarcopenic individuals and the impact of resistance exercise and nutrition interventions.

Journal of the International Society of Sports Nutrition·2025
Same author

Disrupting CARMA3 Signaling with Triptolide Reverses Sorafenib Resistance in Hepatocellular Carcinoma.

International journal of medical sciences·2025

Related Experiment Video

Updated: May 2, 2026

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
12:00

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro

Published on: July 5, 2017

18.7K

Neuroprotective flavonoids from Flemingia macrophylla.

Young-Ji Shiao1, Chuen-Neu Wang, Wan-Yu Wang

  • 1National Research Institute of Chinese Medicine, Taipei, Taiwan, Republic of China.

Planta Medica
|October 6, 2005
PubMed
Summary

Researchers identified novel flavonoids from Flemingia macrophylla with significant potential for neuroprotection. These compounds demonstrated efficacy in protecting neuronal cells against amyloid-beta induced toxicity.

More Related Videos

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade
09:50

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade

Published on: August 14, 2019

8.6K
Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria
06:38

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria

Published on: February 28, 2025

767

Related Experiment Videos

Last Updated: May 2, 2026

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
12:00

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro

Published on: July 5, 2017

18.7K
Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade
09:50

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade

Published on: August 14, 2019

8.6K
Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria
06:38

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria

Published on: February 28, 2025

767

Area of Science:

  • Natural Product Chemistry
  • Neuropharmacology
  • Medicinal Plant Research

Background:

  • Alzheimer's disease is characterized by amyloid-beta (Abeta) induced neurotoxicity.
  • Natural products are a promising source for neuroprotective agents.
  • Flemingia macrophylla is a medicinal plant with potential therapeutic properties.

Purpose of the Study:

  • To isolate and characterize new compounds from Flemingia macrophylla.
  • To evaluate the neuroprotective activity of isolated compounds against Abeta-induced neurotoxicity.
  • To identify potential therapeutic leads for neurodegenerative diseases.

Main Methods:

  • Fractionation of Flemingia macrophylla aerial parts guided by an Abeta-induced neurotoxicity blocking assay.
  • Structure elucidation of new compounds using spectroscopic data.
  • In vitro testing of isolated compounds for neuroprotective effects against Abeta-induced neuronal damage.

Main Results:

  • Three new flavonoids: fleminginin (1), flemingichromone (2), and flemingichalcone (3), along with twenty known compounds, were isolated.
  • Compounds 2, osajin (4), 5,7,4'-trihydroxy-6,8-diprenylisoflavone (5), 5,7,4'-trihydroxy-6,3'-diprenylisoflavone (6), and aureole (7) exhibited significant neuroprotective activity.
  • Effective concentrations (EC50) for neuroprotection ranged from 4.47 +/- 0.65 microM to 31.43 +/- 3.16 microM.

Conclusions:

  • Flemingia macrophylla is a rich source of bioactive flavonoids with potent neuroprotective properties.
  • Flemingichromone (2) and other isolated compounds show promise as therapeutic agents against Abeta-induced neurotoxicity.
  • Further research into these compounds could lead to novel treatments for Alzheimer's disease and other neurodegenerative conditions.